KRSNAA DIAGNOSTICS LTD Valuation
KRSNAA · Healthcare · Current price ₹558.35
Is KRSNAA DIAGNOSTICS LTD undervalued?
DocStoX estimates the fair value of KRSNAA DIAGNOSTICS LTD at ₹797 per share, versus the current market price of ₹558. That puts the stock about +42.7% below our fair-value estimate, which we read as "Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹272), Relative P/E (₹2,048), Graham floor (₹443), Analyst target (₹790). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹272 (bear) to ₹797 (base) to ₹2,048 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
KRSNAA DIAGNOSTICS LTD trades at a P/E of 21.8x and a P/B of 1.9x, with a dividend yield of 0.4%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on KRSNAA DIAGNOSTICS LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.